The major indices on the Tel Aviv Stock Exchange recorded losses between 1.36 percent and 2.32 percent on Monday.
Teva Pharmaceuticals fell 3.54 percent. In New York, where the stock markets were experiencing similar losses in early trading, the generic drug leader was down almost 14 percent, reaching a low for 2019.